Previous Article | Next Article 
Applied and Environmental Microbiology, February 2000, p. 599-605, Vol. 66, No. 2
Department of Molecular Biology, University
of Gda
Received 19 August 1999/Accepted 19 November 1999
For biodetection of mutagenic pollution of marine environments, an
organism naturally occurring in these habitats should be used. We found
that marine bacterium Vibrio harveyi may be an appropriate
bioindicator of mutagenic pollution. For positive selection of mutants,
we developed a simple method for isolation of V. harveyi
mutants resistant to neomycin. We constructed genetically modified
V. harveyi strains that produce significantly more
neomycin-resistant mutants upon treatment with low concentrations of
mutagens than the wild-type counterpart. The sensitivity of the
mutagenicity test with the V. harveyi strains is at least
comparable to (if not higher than) that of the commonly used Ames test,
which uses Salmonella enterica serovar Typhimurium strains.
Therefore, we consider that the V. harveyi strains
described in this report could be used as potential bioindicators of
mutagenic pollution of marine environments.
Mutagenic pollution of natural
environments seems to be a general and serious problem (see, for
instance, information provided by the U.S. Environmental Protection
Agency [6]) that has been extensively investigated
(the Environmental Mutagen Information Center database contains
over 20,000 citations to literature on agents that have been tested for
mutagenic activity; see
http://www.nlm.nih.gov/pubs/factsheets/emicfs.html). This problem
also concerns marine habitats. Therefore, detection of the presence of
mutagens in the environment is important. This is not an easy
procedure, as mutagenic components usually occur in natural habitats at
low concentrations. Moreover, mutagens are only a fraction of
contaminating chemicals in natural environments. Thus, biological
mutagenicity tests seem to be more sensitive and accurate than chemical analyses.
The most commonly used mutagenicity test is that described by Ames
(1) and subsequently modified by Ames and coworkers (2,
13). In this test, a series of genetically modified
Salmonella enterica serovar Typhimurium strains are used.
The presence of mutations in his genes allows positive
selection of his+ revertants on minimal agar
plates. A deletion of the uvrB gene in most of these tester
strains ensures a higher efficiency of mutagenesis due to inactivation
of one of the bacterial DNA repair systems (2). Moreover,
these bacteria bear the rfa mutation, which causes a partial
loss of the lipopolysaccharide barrier that coats the surface of the
bacteria and increases permeability to large molecules (including some
mutagens) that do not penetrate the normal cell wall (2).
Some of these strains harbor, in addition, plasmid pKM101, which
contains the mucA and mucB genes, responsible for
the enhancement of an error-prone DNA repair system (14, 22,
25).
Although the Ames test is very useful for detecting mutagens under
laboratory conditions, we considered that for monitoring of marine
environments, an organism that naturally lives in these habitats should
be used. Vibrio harveyi is a free-living bacterium found in
diverse marine environments (18, 19). Moreover, it is easily
cultivated under laboratory conditions and completely safe to work with
as a nonpathogenic microbe. Therefore, we have chosen V. harveyi as an organism that could serve as a bioindicator of
mutagenic pollution of marine environments. We aimed to genetically modify this bacterium to obtain a highly mutagenic strain that would
allow the detection of low concentrations of mutagens. On the other
hand, since we wanted to construct a bacterium that could be used as a
potential bioindicator in marine habitats, we wanted to introduce as
few genetic changes as possible to avoid obtaining bacteria unable to
survive under natural environmental conditions.
Bacterial strains, bacteriophage, and plasmids.
Bacterial
strains are listed in Table 1. A
thermoinducible bacteriophage, P1CMcrl100, has already been
described (17). Plasmid pSUPTn5pMCS
(12) bears a Tn5-derived transposon carrying a
trimethoprim resistance gene. For construction of plasmid pAB91273, the
SspI-ScaI fragment (containing the
mucA and mucB genes) of plasmid pGW1700
(16) was inserted into the EcoRI site of plasmid pFF1 (7). The genetic engineering procedures used for the
construction of the plasmid described above were performed as described
by Sambrook et al. (20).
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Genetically Modified Vibrio harveyi
Strains as Potential Bioindicators of Mutagenic Pollution of
Marine Environments
,1,2
grzyn1,*
sk1 and Laboratory of Molecular
Biology affiliated with University of
Gdask,2 Institute of Biochemistry
and Biophysics, Polish Academy of Sciences, 80-822 Gdask,
and Marine Biology Center, Polish Academy of Sciences,
81-847 Gdynia,3 Poland
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
TABLE 1.
Bacterial strains
Culture media. Luria-Bertani (LB) and BOSS media have already been described (10, 20). Minimal medium 3 (26) was used, but for V. harveyi cultivation, the concentration of NaCl was 3%. RGMC medium was described previously (23), but NaCl was added to a final concentration of 3%. Antibiotics were added (when necessary) to the following concentrations: amplicillin up to 50 µg/ml, chloramphenicol up to 35 µg/ml, trimethoprim up to 200 µg/ml, rifampin up to 50 µg/ml, and neomycin up to 50 µg/ml.
Bacterial conjugation. Conjugation between Escherichia coli (donor) and V. harveyi (recipient) strains was performed by a previously described method (23).
UV sensitivity assays. Bacteria were grown in LB (E. coli) or BOSS (V. harveyi) medium at 37°C (E. coli) or 30°C (V. harveyi) to an optical density at 575 nm (OD575) of 0.3. The culture was centrifuged (2,000 × g, 10 min), and the bacterial pellet was suspended in an equal volume of minimal medium salts (27) (E. coli) or the same salts but containing 3% NaCl (V. harveyi). Five milliliters of the suspension was transferred to a petri dish and UV irradiated. Bacteria were titrated on LB (E. coli) or BOSS (V. harveyi) agar plates at 37°C (E. coli) or 30°C (V. harveyi), and the fractions of survivors were calculated. For the agar plate test, bacteria were streaked across the LB (E. coli) or BOSS (V. harveyi) plate, and sectors of the plate were irradiated with different UV doses. The plate was incubated overnight at 37°C (E. coli) or 30°C (V. harveyi), and growth inhibition was estimated.
Crystal violet sensitivity assays. Serial dilutions of the bacterial culture grown in LB (Salmonella serovar Typhimurium) or BOSS (V. harveyi) medium (to an OD575 of 0.3) were spread on LB (Salmonella serovar Typhimurium) or BOSS (V. harveyi) plates containing no crystal violet or different concentrations of this reagent. The plates were incubated overnight, and the fractions of survivors were calculated.
Transposon mutagenesis of V. harveyi. E. coli S17-1 bearing plasmid pSUPTn5pMCS was lysogenized with phage P1CMcrl100 as described previously (17). The lysogenic strain was cultivated for 6 days in LB medium at 30°C, with 1:100 dilution into fresh medium every day. Following thermal induction of the prophage (17), the phage lysate was used for lysogenization of E. coli MC1061 with selection for trimethoprim resistance (200 µg/ml). A strain containing the P1CMcrl100Tn5Tp prophage was then used for propagation of the phage after thermal induction. The phage lysate was used for the transduction of V. harveyi BB7 (with selection for trimethoprim resistance as described above) by a previously described procedure (17) but without the addition of CaCl2, as we found that this reagent caused problems with V. harveyi growth. Since phage P1 can adsorb to V. harveyi cells but is not able to replicate in this bacterium, we considered that most of the trimethoprim-resistant cells contained Tn5Tp integrated into the host chromosome due to its transposition from phage DNA. From each independent experiment, only one V. harveyi mutant was chosen for further analysis.
Mutagenicity tests. For the plate tests, 4 × 106 V. harveyi cells grown in BOSS medium to mid-log phase (OD575, 0.2) were spread on BOSS plates containing various amounts of mutagens. Plates were incubated for 48 h at 30°C, and colonies were counted. For the liquid medium tests, bacteria were grown in BOSS medium (short-term test) or minimal medium 3 containing 3% NaCl (long-term test) in the presence of different amounts of mutagens for various times (the experiments were started when bacterial cultures reached an OD575 of 0.1). Bacteria were titrated on BOSS plates and BOSS plates with neomycin (final concentration, 50 µg/ml), and the fraction of neomycin-resistant mutants was calculated.
| |
RESULTS |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
UV sensitivity of V. harveyi. Organisms used as bioindicators of mutagenic pollution should be relatively sensitive to mutagens. Therefore, we tested the UV sensitivity of wild-type V. harveyi BB7. We found that this bacterium is significantly more sensitive to UV irradiation than wild-type E. coli MG1655 (Fig. 1). Therefore, we considered that V. harveyi BB7 can be used for further work on the construction of the bioindicator strains.
|
Sensitivity of V. harveyi to crystal violet. Some mutagens cannot significantly enhance a number of bacterial mutants, as they are not able to enter the cell through the envelope of certain bacteria, including Salmonella serovar Typhimurium (2). In the Ames test, this problem has been overcome by using rfa mutants of Salmonella serovar Typhimurium, which have changes in lipopolysaccharide that allow the penetration of many mutagens into the cells (2, 13).
Crystal violet is one of the reagents inhibiting bacterial grow only when it can enter cells efficiently. Therefore, crystal violet can be used in tests for bacterial cell envelope permeability by simply measuring the sensitivity of cells to it (2, 13). Wild-type Salmonella serovar Typhimurium is resistant to crystal violet (Fig. 2) because this reagent cannot penetrate the cells (13), while the survival of rfa mutants in the presence of crystal violet is considerably lower (Fig. 2) because the mutation permits large molecules (such as crystal violet) to enter and kill the bacteria (13). We found that the sensitivity of V. harveyi BB7 to crystal violet is even higher than that of the Salmonella serovar Typhimurium rfa mutant used in the Ames test (Fig. 2). These results indicate that for using V. harveyi in mutagenicity tests, there is no need for isolation or construction of rfa or other mutations affecting lipopolysaccharide structure.
|
Isolation of V. harveyi mutants very sensitive to UV irradiation. The results presented above indicated that V. harveyi may be a suitable organism for the bioindication of mutagens. Therefore, we aimed to construct a modified strain of this bacterium which would possess even more features useful in biological tests for the presence of mutagens in marine environments. The first step was to isolate a mutant very sensitive to UV irradiation. We performed transposon mutagenesis and isolated over 80 independent mutants (only 1 mutant was taken from each mutagenesis experiment). Among these mutants, six were very sensitive to UV irradiation, as tested by the plate assay (growth of the wild-type V. harveyi strain was still observed at a UV dose of 15 J/m2, whereas complete inhibition of growth of the six mutants was observed upon UV irradiation at a dose as low as 7 J/m2). However, we found that of these six mutants, five had simultaneously lost the ability to luminesce. Because of this additional phenotype, for further studies we chose the mutant that was luminescent and very sensitive to UV irradiation. We named this strain BB7X.
Construction of V. harveyi strains bearing a plasmid expressing the mucA and mucB genes. Apart from isolating appropriate mutants, enhanced mutagenesis in bacteria may be achieved by introducing mucA and mucB genes, originally present in plasmid R46 and in its derivative, pKM101 (16). Expression of these genes causes an increase in the efficiency of an error-prone DNA repair system. We have constructed plasmid pAB91273, bearing the origin of replication (oriV) from plasmid RK2, the oriT region from RK2, the mucA and mucB genes, and ampicillin resistance and chloramphenicol resistance genes. Following transformation of E. coli, this plasmid was introduced into V. harveyi strains by conjugation and was found to be stably maintained in these strains (data not shown). We named strains BB7 and BB7X bearing plasmid pAB91273 BB7M and BB7XM, respectively.
Positive selection for V. harveyi mutants.
In
order to use V. harveyi strains as bioindicators of
mutagens, we had to develop a system for the positive selection of mutants. V. harveyi is sensitive to neomycin, but we found
that neomycin-resistant mutants appear spontaneously at a low frequency (about 10
5 to 104). This frequency is
nevertheless higher than that of the appearance of specific
substitution mutants (see, for instance, reference 13). This fact is due to the nature of neomycin
action. Neomycin is an aminoglycoside antibiotic that interferes with
decoding at site A at the ribosome during translation (5).
Resistance to this antibiotic occurs as a result of various rRNA
modifications in the decoding site (5).
Mutagenicity tests using V. harveyi strains. The wild-type V. harveyi strain (BB7), its UV-sensitive mutant derivative (BB7X), and strains bearing plasmid pAB91273 (BB7M and BB7XM) were assayed in mutagenicity tests. We used several mutagens previously used in classical mutagenicity tests (13).
In the first type of experiment, we followed the procedure used in the Ames test (13); i.e., dilutions of a bacterial culture were spread on an agar plate containing a mutagen, and after 48 h of incubation the number and percentage of neomycin-resistant mutants were determined. An example of the dose-response effects of mutagens is presented in Fig. 3, and the results are summarized in Fig. 4. We found that even wild-type V. harveyi produced an increased number of neomycin-resistant mutants on plates with tested mutagens. Generally, more mutants appeared when strain BB7X was tested. However, the best results were obtained with strains BB7M and BB7XM; BB7M responded especially effectively to practically all tested mutagens. Different numbers of spontaneous neomycin-resistant mutants appeared (the lowest number for BB7 and the highest number for BB7M), but the numbers of mutagen-induced neomycin-resistant colonies were significantly higher.
|
|
|
|
|
| |
DISCUSSION |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
We found that V. harveyi possesses several features making it a potential bioindicator of mutagenic pollution of marine environments. These features are as follows: (i) it is a free-living bacterium found in diverse marine environments (18, 19); (ii) it can be easily cultivated under laboratory conditions; (iii) it is a nonpathogenic microbe and thus is completely safe to work with; and (iv) neomycin-resistant mutants can be easily isolated, and their frequency increases in the presence of mutagens (Fig. 3 to 7). Genetic modifications of the wild-type V. harveyi strain by isolation of a transposon mutant very sensitive to UV irradiation and introduction of a plasmid bearing mucA and mucB genes led to the construction of a series of strains that can be used in mutagenicity tests.
Different strains produced the largest numbers of mutants in response to various kinds of mutagens (Fig. 4, 6, and 7); thus, we recommend the use of a set of strains for the detection of an unknown mutagen rather than only one strain, as in the Ames test (13). Nevertheless, strain BB7M responded to all tested mutagens in the plate mutagenicity assay (Fig. 4) and seems to be the most general test strain, since all previously described Salmonella serovar Typhimurium strains responded to a significantly more narrow spectrum of mutagens (13). Like strain BB7M in the plate assay, strain BB7X responded to all tested mutagens in the liquid medium assay (Fig. 6 and 7); thus, it may also be considered a general test strain.
It is intriguing that strains BB7M and BB7X often showed a higher percentage of mutants (Fig. 4) or a more significant increase in the fraction of mutants (Fig. 6 and 7) than strain BB7XM. One might expect that BB7XM should be more mutagenic than other test strains used in this work because it bears both a mutation causing high UV sensitivity and a plasmid expressing mucA and mucB genes. On the other hand, the very high mutagenicity of BB7XM may cause the appearance of lethal mutations at a rate significantly higher than that occurring in other strains. Thus, the viability of BB7XM in the presence of mutagens (especially at higher concentrations) is considerably decreased, and many potential neomycin-resistant mutants may not be detected due to the simultaneous appearance of lethal mutations in the same cells. According to this prediction, the best results with strain BB7XM were often observed at lower mutagen concentrations (Fig. 6 and 7). Therefore, it seems that BB7XM may be particularly useful in tests where very small amounts of mutagen(s) occur.
The sensitivity of the mutagenicity tests described in this report is at least comparable to (if not higher than) that obtained in the Ames test, which uses Salmonella serovar Typhimurium mutant strains (compare Fig. 4 in this article with Table 4 in reference (13)). However, note that in the Ames test, 1 × 108 to 2 × 108 bacteria are used per plate (13); in our test, we spread 4 × 106 cells per plate and obtained similar numbers of mutants (compare Fig. 4 in this article with Table 4 in reference (13)). A relatively high fraction of V. harveyi mutants appearing in the presence of mutagens was confirmed in the second type of mutagenicity test, in which bacteria were cultivated in liquid media (Fig. 6 and 7). The possibility of using a relatively small number of bacterial cells should be important for the bioindication of mutagenic pollution of marine environments, as it might be difficult to obtain a very high density of test bacteria in natural habitats, even assuming their immobilization on a carrier surface or trapping with a vessel permeable for mutagenic molecules but not for bacterial cells.
The use of bioluminescent bacteria for the detection of toxic chemicals was described (4), and V. harveyi was used as a test organism in toxicity studies (11, 24). In those studies, the toxicity of different chemicals was determined by a relatively simple method based on measuring changes in bioluminescence. However, toxicity assays should be distinguished from mutagenicity tests. Toxic agents are not always mutagens, and mutagenic chemicals are often toxic only at relatively high concentrations. Therefore, although the previously described bioluminescence assays (4, 11, 24) are simple, they can be useful for the detection of toxic substances rather than mutagens that occur in natural habitats in concentrations too low to provoke serious toxic effects in bacterial cells. Recently, a system for the detection of mutagenic repair in E. coli, based on a fusion plasmid containing the E. coli umuC gene and V. harveyi luxAB genes, has been developed (9). However, like Salmonella serovar Typhimurium used in the Ames test, E. coli is not a marine bacterium; thus, it may be successfully used in laboratory conditions rather than in mutagenicity assays for natural marine environments.
In conclusion, here we describe the use of V. harveyi strains as bioindicators of the presence of mutagens at low concentrations. The assays proposed in this report are very simple, as they are based on positive selection of bacterial mutants (neomycin-resistant mutants) on agar plates. The most important advantages of the mutagenicity tests described in this report are that (i) low concentrations of mutagens can be detected; (ii) V. harveyi is a marine bacterium, so that the detection of mutagens present in natural marine environments is possible; and (iii) unlike Salmonella serovar Typhimurium, V. harveyi is a nonpathogenic bacterium and completely safe to work with. The last item could also be valuable for classification schemes for biohazardous organisms.
| |
ACKNOWLEDGMENT |
|---|
This work was supported by the Polish State Committee for Scientific Research (KBN; project 6 P04C 100 12).
| |
FOOTNOTES |
|---|
*
Corresponding author. Mailing address: Department of
Molecular Biology, University of Gdask, K
adki 24, 80-822 Gdask, Poland. Phone: 48 (58) 346 3014. Fax: 48 (58) 301 0072. E-mail: wegrzyn{at}biotech.univ.gda.pl.
Present address: Department of Biology and Pharmaceutical Botany,
Faculty of Pharmacy, Medical University of Gdask, 80-416 Gdask, Poland.
| |
REFERENCES |
|---|
|
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
|
|---|
| 1. | Ames, B. N. 1971. The detection of chemical mutagens with enteric bacteria, p. 267-282. In A. Hollaender (ed.), Chemical mutagens, principles and methods for their detection. Plenum Press, New York, N.Y. |
| 2. |
Ames, B. N.,
F. D. Lee, and W. E. Durston.
1973.
An improved bacterial test system for the detection and classification of mutagens and carcinogens.
Proc. Natl. Acad. Sci. USA
70:782-786 |
| 3. |
Belas, R.,
A. Mileham,
D. Cohn,
M. Hilmen,
M. Simon, and M. Silverman.
1982.
Bacterial luminescence: isolation and expression of the luciferase genes from Vibrio harveyi.
Science
218:791-793 |
| 4. | Bulich, A. A., and D. L. Isenberg. 1981. Use of the luminescent bacterial system for the rapid assessment of aquatic toxicity. ISA Trans. 20:29-33[Medline]. |
| 5. | Dahlberg, A. E. 1989. The functional role of ribosomal RNA in protein synthsis. Cell 57:525-529[CrossRef][Medline]. |
| 6. | Davey, K. 1999. EPA's strategy for priority persistent, bioaccumulative, and toxic (PBT) pollutants, p. 9. In G. McDonald, D. Sheridan, and M. Wigginton (ed.), Chemicals in our community, vol. 2. Office of Pollution Prevention and Toxics, U.S. Environmental Protection Agency, Washington, D.C. |
| 7. |
Durland, R. H.,
A. Toukdarian,
F. Fang, and D. R. Helinski.
1990.
Mutations in the trfA replication gene of the broad-host-range plasmid RK2 result in elevated plasmid copy number.
J. Bacteriol.
172:3859-3867 |
| 8. |
Jensen, K. F.
1993.
The Escherichia coli "wild types" W3110 and MG1655 have an rph frameshift mutation that leads to pyrimidine starvation due to low pyrE expression levels.
J. Bacteriol.
175:3401-3407 |
| 9. | Justus, T., and S. M. Thomas. 1998. Construction of a umuC'-luxAB plasmid for the detection of mutagenic DNA repair via luminescence. Mutat. Res. 398:131-141[Medline]. |
| 10. |
Klein, G.,
M.  mijewski,
J. Krzewska,
M. Czeczatka, and B. Lipiska.
1998.
Cloning and characterization of the dnaK heat shock operon of the marine bacterium Vibrio harveyi.
Mol. Gen. Genet.
259:179-189[CrossRef][Medline].
|
| 11. | Lange, J. H., and K. W. Thomulka. 1997. Use of the Vibrio harveyi toxicity test for evaluating mixture interactions of nitrobenzene and dinitrobenzene. Ecotoxicol. Environ. Safety 38:2-12[CrossRef][Medline]. |
| 12. |
MacKenzie, C.,
M. Chidambaram,
E. J. Sodergren,
S. Kaplan, and G. M. Weinstock.
1995.
DNA repair mutants of Rhodobacter sphaeroides.
J. Bacteriol.
177:3027-3035 |
| 13. | Maron, D. M., and B. N. Ames. 1983. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113:173-215[CrossRef][Medline]. |
| 14. |
McCann, J.,
N. E. Springarn,
J. Kobori, and B. N. Ames.
1975.
Detection of carcinogens and mutagens: bacterial tester strains with R factor plasmids.
Proc. Natl. Acad. Sci. USA
72:979-983 |
| 15. |
Meissner, P. S.,
W. P. Sisk, and M. L. Berman.
1987.
Bacteriophage  cloning system for the construction of directional cDNA libraries.
Proc. Natl. Acad. Sci. USA
84:4171-4175 |
| 16. | Perry, K. L., and G. C. Walker. 1982. Identification of plasmid (pKM101)-coded proteins involved in mutagenesis and UV resistance. Nature 300:278-281[CrossRef][Medline]. |
| 17. | Rosner, J. L. 1972. Formation, induction, and curing of bacteriophage P1 lysogens. Virology 49:679-689. |
| 18. |
Ruby, E. G., and J. G. Morin.
1979.
Luminous enteric bacteria of marine fishes: a study of their distribution, densities, and dispersion.
Appl. Environ. Microbiol.
38:406-411 |
| 19. |
Ruby, E. G.,
E. P. Greenberg, and J. W. Hastings.
1980.
Planktonic marine luminous bacteria: species distribution in the water column.
Appl. Environ. Microbiol.
39:302-306 |
| 20. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 21. | Sanderson, K. E., A. Hessel, and B. A. D. Stocker. 1996. Strains of Salmonella typhimurium and other Salmonella species used in genetic analysis, p. 2496-2503. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. American Society for Microbiology, Washington, D.C. |
| 22. | Shanabruch, W. G., and G. C. Walker. 1980. Localization of the plasmid (pKM101) gene(s) involved in recA+ lexA+-dependent mutagenesis. Mol. Gen. Genet. 179:289-297[CrossRef][Medline]. |
| 23. | Simon, R., U. Priefer, and A. Puhler. 1983. A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Bio/Technology 1:37-45. |
| 24. | Thomulka, K. W., and J. H. Lange. 1996. A mixture toxicity study employing combinations of tributyltin chloride, dibutyltin dichloride, and tin chloride using the marine bacterium Vibrio harveyi as the test organism. Ecotoxicol. Environ. Safety 34:76-84[CrossRef][Medline]. |
| 25. | Walker, G. C., and P. P. Dobson. 1979. Mutagenesis and repair deficiencies of Escherichia coli umuC mutants are suppressed by the plasmid pKM101. Mol. Gen. Genet. 172:17-24[CrossRef][Medline]. |
| 26. |
Wgrzyn, G., and K. Taylor.
1992.
Inheritance of the replication complex by one of two daughter copies during plasmid replication in Escherichia coli.
J. Mol. Biol.
226:681-688[CrossRef][Medline].
|
| 27. |
Wgrzyn, G.,
P. Neubauer,
S. Krueger,
M. Hecker, and K. Taylor.
1991.
Stringent control of replication of plasmids derived from coliphage .
Mol. Gen. Genet.
225:94-98[Medline].
|
Applied and Environmental Microbiology, February 2000, p. 599-605, Vol. 66, No. 2
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sikora, A. E., Zielke, R., Datta, K., Maddock, J. R.
(2006). The Vibrio harveyi GTPase CgtAV Is Essential and Is Associated with the 50S Ribosomal Subunit. J. Bacteriol.
188: 1205-1210
[Abstract] [Full Text] -
Zielke, R., Sikora, A., Dutkiewicz, R., Wegrzyn, G., Czyz, A.
(2003). Involvement of the cgtA gene function in stimulation of DNA repair in Escherichia coli and Vibrio harveyi. Microbiology
149: 1763-1770
[Abstract] [Full Text] -
Kuchanny-Ardigo, D., Lipinska, B.
(2003). Cloning and characterization of the groE heat-shock operon of the marine bacterium Vibrio harveyi. Microbiology
149: 1483-1492
[Abstract] [Full Text] -
Zielke, R., Wegrzyn, G.
(2001). A Vibrio harveyi insertional mutant in the cgtA (obg, yhbZ) gene, whose homologues are present in diverse organisms ranging from bacteria to humans and are essential genes in many bacterial species. Microbiology
147: 183-191
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»